Biotech Stock Still 700%: What Investors Should Do Today
A biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Using emergency funds to pay off credit card debt can be tempting but may leave you vulnerable. Weigh the pros and cons to make the best decision.
23,601 articlesA biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
AMD has surged dramatically, up 320% over the past year, sparking questions about whether investors should shift focu...
Retirees should anchor planning on cash flow rather than asset size. Here is how the math stacks up in today's market...
Dayton, Ohio pauses its ALPR program as privacy concerns rise. ohio city workers covering the cameras have put 72 dev...
SpaceX has vaulted to a $2.8 trillion valuation, leaving investors debating whether the growth story justifies the pr...
Volatility returns to FX markets in 2026. This forex.com review highlights pricing, safety, and platform options trad...
A hypothetical SpaceX Nasdaq move could quietly lift required minimum distributions for retirees. This piece breaks d...
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
The Pentagon designated Anthropic as a supply-chain risk, triggering an immediate halt to certain contracts and a six...
A new venue now enables 24/7 crypto trading, including weekends. Early weekend data shows growing interest and liquid...
Paris-based Capital B raises €15.2 million in a private round to buy 182 BTC, expanding its Bitcoin treasury holdings...
A Roth IRA can dramatically boost after-tax income from dividend stocks that generate steady cash flow. This report b...